Severe asthma and fungi: current evidence (Q37775970)

23 August 2017

1 reference

title

Severe asthma and fungi: current evidence (English)

1 reference

23 August 2017

0 references

1

1 reference

23 August 2017

Dheeraj Gupta

2

1 reference

23 August 2017

publication date

22 July 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

49 Suppl 1

1 reference

23 August 2017

page(s)

S150-7

1 reference

Severe asthma: approach and management

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

21 January 2018

Severe asthma in adults

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Clinical review: severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

High frequency of atopic asthma in a pulmonary clinic population.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Atopic status in patients with brittle and non-brittle asthma: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Exposure and sensitization to indoor allergens: association with lung function, bronchial reactivity, and exhaled nitric oxide measures in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

The link between fungi and severe asthma: a summary of the evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

The effect of outdoor fungal spore concentrations on daily asthma severity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

New Orleans asthma. V. Relationship between Charity Hospital asthma admission rates, semiquantitative pollen and fungal spore counts, and total particulate aerometric sampling data

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Fungal and other spore counts as predictors of admissions for asthma in the Trent region

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Effect of environmental molds on risk of death from asthma during the pollen season.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Mold sensitization is common amongst patients with severe asthma requiring multiple hospital admissions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Specific IgE response to trichophyton and asthma severity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Allergic bronchopulmonary stemphyliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Allergic bronchopulmonary disease caused by Curvularia lunata and Drechslera hawaiiensis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Mixed allergic bronchopulmonary fungal disease due to Pseudallescheria boydii and Aspergillus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Allergic bronchopulmonary fungal disease caused by Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Anti-mycotics suppress interleukin-4 and interleukin-5 production in anti-CD3 plus anti-CD28-stimulated T cells from patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Itraconazole suppresses an elicitation phase of a contact hypersensitivity reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Expression of immunomodulatory genes in human monocytes induced by voriconazole in the presence of Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: an analysis of 155 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Clinical significance of decline in serum IgE levels in allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

A comparison of the prevalence of sensitization to antigens among asthmatics in Cleveland and London

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Sensitization to Aspergillus antigens and occurrence of allergic bronchopulmonary aspergillosis in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with acute severe asthma in a respiratory intensive care unit in North India.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Link between allergic asthma and airway mucosal infection suggested by proteinase-secreting household fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Interferon-gamma is necessary for the expression of hypersensitivity pneumonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Comparison of skin prick tests with specific serum immunoglobulin E in the diagnosis of fungal sensitization in patients with severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Aspergillus antigens: which are important?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Recombinant Aspergillus fumigatus allergens: from the nucleotide sequences to clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

"Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Adverse events associated with itraconazole in 189 patients on chronic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Cushing's syndrome due to pharmacological interaction in a cystic fibrosis patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Control of Exposure to Mite Allergen and Allergen-Impermeable Bed Covers for Adults with Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Epidemiology of Allergic Bronchopulmonary Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Allergic Bronchopulmonary Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

Clinical Manifestations and Natural History of Allergic Bronchopulmonary Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.504752

10.3109/13693786.2010.504752

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference